Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Butterfly Pivotal Study

NCT: NCT05341661 · ACTIVE_NOT_RECRUITING

NCT IDNCT05341661
StatusACTIVE_NOT_RECRUITING
Start Date2022-04-07
Completion2029-12-31

Brief Summary

A prospective, multicenter, blind randomized (2:1) controlled study comparing the International Prostate Symptom Score (IPSS) of the Active arm to the IPSS of the control arm at the 3 months follow-up and active arm IPSS score change from time zero to 12 months. Patients in the active arm undergo Butterfly device treatment. Patients in the control arm undergo a sham rigid cystoscopy procedure

Frequently Asked Questions

What is Butterfly Pivotal Study?

Butterfly Pivotal Study is a clinical trial registered under NCT05341661. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05341661?

The current status of NCT05341661 (Butterfly Pivotal Study) is: ACTIVE_NOT_RECRUITING.

When did Butterfly Pivotal Study start?

Butterfly Pivotal Study started on 2022-04-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.